Identification of expression profiles and transcription factors during EGFR‐TKI acquired resistance in LUAD

Abstract Lung cancer is one of the most‐common malignant tumors while lung adenocarcinoma (LUAD) serves as the major subtype of lung cancer. The epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs) are an important choice in LUAD targeted therapies. However, EGFR‐TKI acquired resi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Lili Feng, Cenzhu Wang, Jiawen Chen, Chenyue Tao, Liuliu Zhang, Luojing Zhou
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-12-01
coleção:	Precision Medical Sciences
Assuntos:	acquired resistance EGFR‐TKI LUAD single‐cell RNA sequencing
Acesso em linha:	https://doi.org/10.1002/prm2.12146
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!